Jamieson Wellness (JWEL) Stock Price, News & Analysis

Company Overview

Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements. The Strategic Partners segment provides contract manufacturing services to consumer health companies and retailers. The company offers health and wellness supplements under the Jamieson brand; health, beauty, and wellness supplements under the Youtheory brand; and foundational formulas, including probiotics, multivitamins, fish oils, vitamin D, and solution-focused products for better sleep or digestion under the Progressive brand. It also provides plant-based products under the Iron Vegan brand; natural health products for health concerns among women, including hormone imbalances, nutrient deficiencies, and sleep and stress management, and others under the Smart Solutions brand; and sports nutrition supplements under the Precision brand. The company offers its contract manufacturing services under the Nurticorp brand. It sells its products to distributors, and retail and wholesale customers. The company was formerly known as Jamieson Intermediate Holdings Ltd. and changed its name to Jamieson Wellness Inc. in May 2017. Jamieson Wellness Inc. was founded in 1922 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: C$29.46 to C$30.55
• 50-Day Range: C$28.01 to C$35.75
• 52-Week Range: C$25.42 to C$38.20
• Volume: 102,838 shs
• Average Volume: 87,896 shs
• Market Capitalization: C$1.28 billion
• P/E Ratio: 32.08
• Dividend Yield: 2.75%
• Price Target: C$39.04
• Consensus Rating: Buy

Jamieson Wellness Stock Analysis - MarketRank™

Jamieson Wellness scored higher than 36% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Jamieson Wellness has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Jamieson Wellness has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Jamieson Wellness is 32.08, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.56.

Price to Earnings Ratio vs. Sector

The P/E ratio of Jamieson Wellness is 32.08, which means that it is trading at a more expensive P/E ratio than the Consumer Defensive sector average P/E ratio of about 11.00.

Price to Book Value per Share Ratio

Jamieson Wellness has a P/B Ratio of 2.62. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for JWEL.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Jamieson Wellness pays a meaningful dividend of 2.50%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Jamieson Wellness does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Jamieson Wellness is 88.26%. Payout ratios above 75% are not desirable because they may not be sustainable.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for JWEL.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

1 people have searched for JWEL on MarketBeat in the last 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Jamieson Wellness insiders have sold 870.98% more of their company's stock than they have bought. Specifically, they have bought C$54,016.00 in company stock and sold C$524,485.00 in company stock.

Percentage Held by Insiders

Only 0.26% of the stock of Jamieson Wellness is held by insiders.

Percentage Held by Institutions

55.62% of the stock of Jamieson Wellness is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

JWEL Stock Analysis - Frequently Asked Questions

How have JWEL shares performed this year?

Jamieson Wellness' stock was trading at C$36.71 at the beginning of 2025. Since then, JWEL stock has decreased by 16.8% and is now trading at C$30.53.
View the best growth stocks for 2025 here.

How do I buy shares of Jamieson Wellness?

Shares of JWEL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Jamieson Wellness own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Jamieson Wellness investors own include Enbridge (ENB), Canadian Natural Resources (CNQ), Crown Castle (CCI), Suncor Energy (SU), Royal Bank of Canada (RY), Algonquin Power & Utilities (AQN) and Bank of Nova Scotia (BNS).

Company Calendar

• Ex-Dividend for 3/14 Dividend: 3/07/2025
• Record date for 3/14 Dividend: 3/14/2025
• Dividend Payable: 3/14/2025
• Today: 3/28/2025

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Consumer Defensive
• Industry: Packaged Foods
• Sub-Industry: Retail
• Current Symbol: TSE:JWEL
• CIK: N/A
• Web: investors.jamiesonwellness.com
• Phone: +1-416-9600052
• Fax: N/A
• Employees: 240
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: C$39.04
• High Stock Price Target: C$46.00
• Low Stock Price Target: C$27.00
• Potential Upside/Downside: +27.9%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Most Recent Fiscal Year): C$0.95
• Trailing P/E Ratio: 32.08
• Forward P/E Ratio: 14.24
• P/E Growth: N/A
• Net Income: C$39.83 million
• Net Margins: 5.57%
• Pretax Margin: N/A
• Return on Equity: 8.99%
• Return on Assets: 4.73%

Debt

• Debt-to-Equity Ratio: 75.70
• Current Ratio: 2.76
• Quick Ratio: 1.08

Sales & Book Value

• Annual Sales: C$715.02 million
• Price / Sales: 1.79
• Cash Flow: C$0.29 per share
• Price / Cash Flow: 103.97
• Book Value: C$11.67 per share
• Price / Book: 2.62

Miscellaneous

• Outstanding Shares: 41,898,345
• Free Float: N/A
• Market Cap: C$1.28 billion
• Optionable: Not Optionable
• Beta: 0.63